🔎 Trials Near Me

Inicio › Migraña › Virginia

Ensayos clínicos de Migraña en Virginia

6 estudios sobre Migraña buscan participantes en Virginia.

Ciudades en Virginia

Texto oficial del estudio (inglés)

Randomized Study in Children and Adolescents With Migraine: Acute Treatment

  • Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
  • Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
  • Pediatric Research of Charlottesville, LLC, Charlottesville
  • y 2 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04649242

Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine

  • Pediatric Associates of Charlottesville, PLC (Private Pediatric Practice), Charlottesville
  • Pediatric Research of Charlottesville, LLC (Regulatory Only), Charlottesville
  • Pediatric Research of Charlottesville, LLC, Charlottesville
  • y 2 más
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 24 sept 2026 · NCT04743141

Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)

  • Pediatric Associates of Charlottesville, PLC /ID# 230628, Charlottesville
  • Children's Hospital of The King's Daughters - Children's Medical Tower /ID# 230581, Norfolk
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 14 sept 2026 · NCT05125302

A Study to Evaluate the Efficacy and Safety of Elismetrep (K-304) in the Acute Treatment of Migraine

  • Health Research of Hampton Roads, Inc. (HRHR), Newport News
  • AMR Clinical - Norfolk, Norfolk
ReclutandoFase 3
Edades de 18 a 75 · Todos los sexos · Actualizado el 20 ago 2026 · NCT07645924

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine

  • Children's Specialty Group - 3 Commercial Place, Norfolk
ReclutandoFase 3
Edades de 6 a 17 · Todos los sexos · Actualizado el 12 jun 2026 · NCT05164172

Rimegepant as Preemptive Treatment for Predictable Trigger-Induced Migraine in Adult Patients in the US

  • MedStar Health: Neurology at McLean, McLean
ReclutandoFase 4
Edades de 18 en adelante · Todos los sexos · Actualizado el 24 dic 2025 · NCT07301008

De ClinicalTrials.gov, datos obtenidos el 30 sept 2026. Cada estudio establece sus propios criterios de elegibilidad; el equipo del estudio decide quién puede participar.